GlcNAc-TV inhibitors (GLYCODesign)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameGlcNAc-TV inhibitors (GLYCODesign)
Drug Alias NameGnT-V inhibitor (GLYCODesign)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A inhibitors
TargetsAlpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlycodesign Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlycodesign Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A